Eric Ofosu Kissi, PhD has a bachelor’s degree in Chemistry from the University of Cape Coast Ghana, followed by a few years of working in the pharmaceutical industry at Ernest Chemist Ltd in Ghana. He was awarded a scholarship from the University of Eastern Finland to study photonics. His master's thesis was on characterising active pharmaceutical ingredients and dosage forms using terahertz spectroscopy. He used the novel scotch tape method to develop quick analytical techniques for these APIs. Using non-invasive Attenuated Total Reflection (ATR) technique of far-infrared spectrometer, he was able to differentiate between original and counterfeit antimalarials. Counterfeit/falsified medicines are drugs that are camouflaged as authentic but lack the quality, safety and efficacy as stipulated by regulatory authorities. Drug counterfeiting is a major worldwide problem and through developing handheld photonic devices, point of care and individuals can use these devices to detect the authenticity of the drugs that they are using. 

​

Recognising there is an interesting link between photonics and pharmaceutics, he pursued his doctorate at the University of Copenhagen, Denmark. He worked on a multidisciplinary research project on understanding the physical stability of amorphous drug molecules. During his research, he uncovered the fundaments and application of, the so-called, beta relaxation (secondary molecular mobility) in amorphous drugs. He developed a thermomechanical method for analysing molecular mobility of amorphous drugs using dynamic mechanical analysis. As part of the project, he was a visiting doctoral researcher at the University of Cambridge, where he worked with variable temperature terahertz measurement. Also, he visited Roskilde university where he worked with dielectric spectroscopy.

​

After been award with his PhD, he was appointed as a postdoctoral fellow at the University of Oslo. Currently, he researches the applicability of 3D printing in the development of personalised drugs and finding new materials for stabilizing amorphous drugs.

His research interests are amorphous drug delivery systems, solid-state pharmaceutics and developing the next generation of development of drugs using 3D printing.